Messages in brief
New information on Herceptin theft
Situation Austria: currently only parallel marketed Italian Herceptin and Alimta are affected (as of 18.4.2014).
The drug Herceptin is approved…
Counterfeit Herceptin (trastuzumab)
Protelos/Osseor
Important information about differences in thromboembolism risk of combined oral contraceptives.
Re-evaluation of the effectiveness of emergency contraception "morning-after pill" started
Incorrect use of Eldisin 5 mg dry vial (Vindesin Sulfate).
The preparation Eldisin 5 mg dry ampoules (active ingredient: vindesine sulfate) has been approved in Austria since March 29, 1984. Vindesine is a…
BASG statement
Federal Office for Safety in Health Care
What does the black triangle mean?
The European Union has introduced a new labeling for medicinal products that are subject to particularly close monitoring.
These medicines are…
Extension of the usability of drug stocks
Many medicinal products, when stored appropriately, remain in compliance with their specifications for much longer than can be expected on the basis…